Theme and Background
This chapter uses the significant market pullback in 2022 as its backdrop (the S&P 500 fell 19% for the year, the seventh worst year since 1926) to explore the dialectical relationship between "time" and "timing" in long-term investing. By comparing the wealth outcomes of ordinary people and highly educated investors, the author argues that simple behaviors sustained over the long term are more effective than complex analysis, and uses this as a transition to the institutional shift from Opportunity Strategy to Patient Capital.
Core Views
- Core Investment Thesis: Long-term compounding (rather than market timing) is the fundamental driver of wealth creation. Short-term market volatility is the norm, and investors should focus on enduring corporate value rather than being swayed by panic.
- Counter-Intuitive Judgments:
- Highly educated, high-income individuals (e.g., former Merrill Lynch executive Richard Fuscone) may go bankrupt due to overconfidence or complex strategies, while a low-educated janitor (Ronald Read) and a secretary (Grace Groner) accumulated millions of dollars in wealth through simple savings and long-term holding of blue-chip stocks.
- The moments of greatest market panic (e.g., after the sharp 2022 decline) are precisely the best opportunities for long-term buying, not times to flee.
Key Arguments and Data
1. The Power of Long-Term Compounding:
- The S&P 500 has delivered an average annual compound return of 9.4% since 1927, despite numerous recessions, wars, inflation, and interest rate hikes.
- The 60/40 stock-bond portfolio fell 17% in 2022, its worst performance since 1937, but remains effective over the long term.
2. Timing vs. Time:
- Research shows that the average retail investor's return impairment stems primarily from poor timing decisions (rather than fund selection or fees), often involving panic selling at market bottoms.
- Morningstar ratings (based on historical performance) have no predictive value; mean reversion is a powerful force in markets.
3. Drawdown Norms for Quality Companies:
- Hendrik Bessembinder's research: The top 100 performing stocks each decade experienced an average drawdown of 33% (lasting about 10 months); in the prior decade, these same stocks had an average drawdown of 52% (lasting 22 months).
- Only 4% of companies drive all market wealth creation over the long term, making it crucial to identify and invest early in such companies.
4. Scarcity of Value Investing:
- Value funds' share of assets under management has fallen from about 25% in the mid-2000s to the current 5-10% (Morningstar data).
- Among actively managed funds, only about 1/4 hold stocks for more than three years; hedge funds trade even more frequently.
5. Performance and Strategy of Patient Capital:
- Opportunity Equity (before fees) returned -35.51% in 2022, underperforming the S&P 500's -18.11%; but since its inception in 1999, it has an annualized return of 6.375%, slightly above the S&P 500's 6.28%.
- The author emphasizes that early investments in long-term winners (e.g., Amazon, RH, Farfetch) caused the strategy's short-term performance to deviate from value peers, but contributed significantly over the long term.
Companies/Assets Involved
| Company/Asset |
Role |
Key Data |
View |
| Amazon |
Long-term winner case |
Author's early investment, top 10 contributor over a decade |
Bullish: Aligns with "long-term compounding capital" strategy |
| RH (Restoration Hardware) |
Same as above |
Same as above |
Bullish |
| Farfetch |
Same as above |
Sold at higher price, significant contribution |
Bullish (partially realized gains) |
| Snickers (Mars) |
Enduring brand case |
Still the best-selling candy in the US since 1962 |
Symbolic case, not an investment target |
| Geico (Berkshire Hathaway) |
Classic value investing case |
Early investment by Buffett and Ben Graham |
Bullish: Model of long-term compounding capital |
| Citadel / Renaissance |
Representative of short-term efficient markets |
Excels in real-time algorithmic trading |
Neutral: Acknowledges short-term advantages, but emphasizes long-term market inefficiency |
Investment Implications
- Directional Advice:
- Buy and Hold: After the sharp 2022 decline, investors should add to positions counter-cyclically, rather than panic and exit. Dollar-cost averaging is an effective strategy.
- Focus on Long-Term Winners: Seek companies capable of sustained capital compounding (e.g., Amazon, RH), even if short-term valuations appear expensive (e.g., high P/E), as long-term returns far exceed accounting metrics.
- Beware of Timing Traps: Avoid decisions based on short-term panic or Morningstar ratings; mean reversion punishes those who chase highs and sell lows.
- Specific Actions:
- Maintain confidence in Patient Capital's Opportunity Strategy; its long-term track record (6.375% annualized since 1999) proves the strategy's effectiveness, and the short-term drawdown (-35.51% in 2022) is normal volatility.
- Watch for the value investing comeback: The share of value funds has fallen to historic lows (5-10%), and signs of a reversal have emerged in the past year or two.
Additional Arguments and Data Supplement
1. Time Dimension and Historical Comparison of the Innovation Stock Bear Market
- Current Bear Market Duration: From its peak in February 2021 to early 2023, the ARK Innovation ETF fell approximately 80%, lasting nearly two years. This is almost on par with the tech stock bear market of the early 2000s (just over two years, with the earliest peaking stocks lasting about three years). Given the faster reaction times of modern markets, this comparison is particularly striking.
- Magnitude of Decline Comparison: The tech sector in the early 2000s fell a cumulative 73% over three years, while ARK fell 75% in 2021-2022, a close match. This suggests the current innovation stock decline may be in its "later innings."
2. Key Differences Between the Current and Early 2000s Periods
- Profitability Differences: A higher proportion of current innovation stocks are loss-making. The market increasingly favors companies actively pursuing profits, which could cause additional pain as management adjusts cost structures.
- Recession Risk: The early 2000s experienced a mild recession, while the likelihood of a current recession remains unknown. A deeper recession could amplify losses further.
3. Valuation Anchoring for Consumer and Cyclical Stocks
- Consumer Stock Decline Comparison: Consumer discretionary stocks fell 37% in 2022, already close to the sector's total decline during the entire early 2000s bear market (approximately 37%). Even compared to the 2007-2009 financial crisis (a 42% decline), the current drop is only 5 percentage points less. This suggests the market has partially priced in recession risk, providing a margin of safety for consumer and cyclical stocks in the portfolio.
| Bear Market Phase |
Consumer Discretionary Decline |
Notes |
| Early 2000s (Mild Recession) |
Approx. 37% |
Current 2022 decline fully matches |
| 2007-2009 (Financial Crisis) |
42% |
Current decline only 5% less |
| 2022 (Current) |
37% |
Valuation correction + recession expectation pricing |
4. Long-Term Shift in Value Strategy
- Interest Rate Environment Reversal: Falling rates in the 2010s favored growth stocks, putting pressure on value strategies. With current interest rates significantly higher, and companies adapting to the new environment, value strategies may enter a period of advantage lasting over a decade.
- Portfolio Structure Advantage: The portfolio is anchored by high-conviction value stocks, while holding a small number of potential long-term winners (expected returns of 5-100x). This unique "value + early-stage compounding" combination offers greater resilience amid macro volatility.
5. 2023 Outlook and Probability Assessment
- Macro Focus Shift: If the market shifts from macro concerns to company fundamentals in 2023, it will benefit value and stock-picking strategies. Current growth and cyclical stocks have fallen to historically extreme levels, consistent with characteristics seen at the end of past bear markets/recessions.
- Probability Assessment: Based on historical patterns, the probability of strong portfolio performance in 2023 is high. Appendix 1 further quantifies the comparison of losses from the 2000 tech bubble with the current innovation bubble, supporting the "later innings" judgment.
Appendix 1: Comparison of Losses from the 2000 Tech Bubble vs. Current Innovation Bubble (Supplemental Data)
| Metric |
2000 Tech Bubble (2000-2003) |
Current Innovation Bubble (2021-2023) |
Difference Analysis |
| Sector/Fund |
Tech Sector (NASDAQ 100) |
ARK Innovation ETF |
Both represent high-growth, high-valuation areas |
| Peak-to-Trough Decline |
Approx. 73% (3 years) |
Approx. 75% (2 years) |
Current decline is more concentrated and faster |
| Duration |
Just over 2 years (earliest peaking stocks ~3 years) |
Nearly 2 years |
Already close to the worst-case historical scenario |
| Core Company Profitability |
Mostly profitable |
Mostly loss-making |
Current adjustment may be more painful |
| Macro Background |
Mild recession |
Recession risk uncertain |
Current uncertainty is higher |
Conclusion: Despite profitability differences and recession risk, the magnitude and duration of the decline are already close to historical extremes, suggesting the innovation stock losses may be nearing an end. Consumer and cyclical stocks have already priced in a recession, and value strategies are experiencing a long-term shift. If macro pressures ease in 2023, the portfolio has significant potential for a rebound.
Theme and Background
This section serves as the appendix to the Patient Capital research report, primarily listing other market analysis materials related to the report's theme, including Christina Siegel's Q4 2022 market highlights and quarterly investment review, as well as reference data sources for the 60/40 portfolio.
Core Viewpoint
This section contains no independent investment views; it merely provides data source explanations and compliance disclosures for the report. The core information is that the 60/40 portfolio data (60% S&P 500 + 40% 10-year Treasury bonds) in the report comes from New York University, while Appendix 1 is based on internal analysis by Miller Value Partners, with data sourced from Bloomberg and 1stock1.com.
Key Arguments and Data
This section contains no specific investment data or arguments, only the following technical explanations:
- 60/40 portfolio composition: 60% S&P 500 + 40% 10-year Treasury bonds
- The S&P 500 Index is a market-capitalization-weighted index covering 500 widely held common stocks
- All historical financial data is unaudited and does not constitute a representation or guarantee
Companies/Assets Involved
- S&P 500 Index: Used as a benchmark index to measure market performance
- 10-year U.S. Treasury bonds: As a fixed-income asset, combined with equities to form the 60/40 strategy
- Christina Siegel: The market analysis author mentioned in the report, but no specific investment advice is provided
Investment Implications
This section offers no investment implications. Investors should note that historical performance data in the report does not predict future results, and all specific securities mentioned are for illustrative purposes only and should not be considered buy or sell recommendations. The reference data sources for the 60/40 portfolio (New York University, Bloomberg, 1stock1.com) can serve as a starting point for independent verification.